portant in the fetal and neonatal periods, and finally, EP studies in human disease.
The monograph tells us that EP is the principle hormone which regulates erythropoiesis. It is a glycoprotein with a molecular weight of 60,000 to 70,000. The kidney produces either the hormone itself or an enzyme activating the plasma substrate. The site of EP production in the kidney is unknown, but the greatest concentration is separated in a "light mitochondrial" fraction. EP acts by causing a committed but undifferentiated cell to differentiate into an erythroblast, and may also have a role in causing maturation of erythroblasts. In bone marrow culture, EP acts sequentially to increase synthesis of RNA, then DNA, and to increase incorporation of iron into red cells and into heme. On a clinical level, anemias due to hemorrhage, hemolysis, and vitamin deficiencies are associated with elevated EP, whereas the anemias of uremia, protein starvation, and chronic inflammation are not. Administration of EP, when it becomes available, should benefit at least the latter conditions. Polycythemias secondary to hypoxia and tumors may be associated with elevated EP levels, whereas primary polycythemias are not.
This information and much more has been acquired largely by using bioassay techniques such as injecting plasma or tissue extracts into the polycythemic mouse and measuring iron incorporation into red cells. In vitro methods for EP measurements are available, but it is yet uncertain that what they measure corresponds to erythropoietic potency. Solution of this problem will be an important breakthrough.
Although the book is generally well written, its readability is occasionally compromised by the authors' scholarly approach. All sides of every debate are presented. A positive statement quoted from one publication is likely to be qualified by a second and contradicted by a third. Paragraphs are sometimes interrupted by several lines of reference numbers. (The last 100 pages of the volume are devoted to the reference list.) The scholarly fair play and footnoting will assist EP researchers but may prove tedious to those with a lesser commitment to this field. There are no tables or figures, but there is an index which seems excellent.
PETER MC PHEDRAN THE BIOCHEMICAL BASIS OF NEUROPHARMACOLOGY. By Jack Cooper, Floyd E. Bloom, and Robert H. Roth. New York, Oxford University Press, 1970. viii, 220 pp. $6.95. This relatively brief monograph consists of an introduction and ten chapters, each of which could be a well organized lecture on the topic it discusses. The rationale for the approach to the book, with its basic orientation towards neurotransmitters, is presented in the introduction. The anatomical and physiological foundation are the subjects of the second chapter and the biochemical approaches are outlined in the third chapter. The next five chapters deal with specific putative transmitters-acetylcholine, catecholamines, serotonin, amino acids (a-amino butyric acid, glycine, and glutamic acid) and others (histamine, prostoglandin, substance-P, etc.), while the final chapter is devoted to cellular mechanisms in memory and learning.
The authors state in the introduction that their objective is to treat what they think are the important aspects of neuropharmacology and to present an integrated view of the multidisciplinary aspects relevant to the development of this rapidly advancing field. They have accomplished their objective admirably. The book is easily readable, the material welldigested and integrated, the illustrations appropriate and clear, and the distribution of space devoted to each topic is consistent with current knowledge. This volume could provide an excellent lecture outline for a portion of a neuropharmacology course and appears to have its origin in such a course.
The references cited are mainly other reviews which can serve as sources for further information. This book is an excellent introduction for students interested in neuropharmacology and can be highly recommended for medical students, psychiatrists and neurologists who wish to become familiar with biological advances in neuropharmacology as well as for graduate students entering this area of research. Of the many textbooks used in the preclinical medical curriculum few have the sustained value of this comprehensive text on Pharmacology. The Fourth Edition continues the tradition of excellence of previous years. This is not the superficial evaluation by one person of 1794 pages, richly packed with detailed information and subtle interpretations. Rather, it is based on the composite experience of the Faculty of the Department of Pharmacology at Yale University. Many chapters have been rewritten in significant detail and have been critically examined by each of us in the preparation of our course lectures and, with perhaps equal frequency, as a source of pharmacological reference in areas related to our fields of investigation. These comments should not be taken to indicate that this book is primarily designed for the medical student and researcher. The hallmark of the First Edition written in 1941, was its excellent organization. The physician faced with a therapeutic problem can rapidly extract essential information and, if necessary, return for a more comprehensive background of the physiological, biochemical or toxicological details.
The introduction of multiple authorship in the Third Edition, an arrangement essential to the scope of material covered, is continued. Despite this, a remarkable consistency of style and presentation is to be found. The chapters which introduce each section of the book provide excellent current reviews of the physiological and biochemical principles of therapy. Documentation of the basic and applied aspects of therapeutics is unexcelled in any currently available textbook. Although in every chapter both original and review articles are quoted for 1968 and 1969, some may feel this renders certain sections out of date in areas in which progress is rapid. In a measure this problem is solved by frequent references to agents that are still in the investigational stage; nevertheless the obligation of the teacher, student or physician to consult current sources for new drug information remains.
